During the past decade, Medpace Clinical Pharmacology Unit conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 9 clinical trials were completed, i.e. on average, 25.7% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 2 clinical trials were completed. i.e. 9.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medpace Clinical Pharmacology Unit" #1 sponsor was "Reata Pharmaceuticals, Inc." with 4 trials, followed by "Daiichi Sankyo, Inc." with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Allena Pharmaceuticals" with 2 trials sponsored and "CinCor Pharma, Inc." with 2 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medpace Clinical Pharmacology Unit" #1 collaborator was "Medpace, Inc." with 5 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Beckloff Associates, Inc." with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Medpace Clinical Pharmacology Unit" are "Healthy" (8 trials), "Healthy Volunteers" (5 trials), "Coronary Artery Disease" (3 trials), "Diabetes Mellitus, Type 2" (3 trials) and "Dyslipidemia" (2 trials). Many other conditions were trialed in "Medpace Clinical Pharmacology Unit" in a lesser frequency.

Most popular intervention types in "Medpace Clinical Pharmacology Unit" are "Drug" (43 trials), "Other" (4 trials), "Biological" (3 trials) and "Combination Product" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "ALLN-346" (2 trials), "CIN-107" (2 trials), "COR388" (2 trials) and "Clopidogrel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Medpace Clinical Pharmacology Unit" are 47 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medpace Clinical Pharmacology Unit". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in Medpace Clinical Pharmacology Unit, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medpace Clinical Pharmacology Unit, 41 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".